FTO and heart failure: Zhang et al. found that the expression of METTL3, METTL4, KIAA1429, FTO, and YTHDF2 was significantly up-regulated in patients with heart failure with preserved ejection fraction (HFpEF) compared to healthy controls, suggesting that m6A methylation may be a therapeutic target for HFpEF interventions [87].